AHC Responds to the PHAC Communtiy Action FUND LOI Process

Good afternoon AHC members and supporters, As you know, AHC has been closely following the results of the Public Health Agency of Canada (PHAC) funding application process, trying to better understand the damage done across our sector. Specifically we completed a member survey 2 weeks ago, and participated in the release of a press statement with CAAN and CAS last week, as well as another news article. Today the AHC sent a letter to Dr. Gregory T...

Action Hepatitis Canada World Hepatitis Day 2016 Advocacy Toolkit

We have prepared social media tools to help you amplify our message this World Hepatitis Day. They can be found below or on our website in English and French. Please share with your communications coordinator. Thank you! World Hepatitis Day 2016 Advocacy Toolkit On Thursday, July 28th, Action Hepatitis Canada will join hundreds of organizations around the world in observing World Hepatitis Day. By taking part in World Hepatitis Day, you can help amp...

Pricing of Hepatitis C Medicines in Canada: AHC Position Statement

Action Hepatitis Canada (AHC) is calling on the government of Canada to review and update legislative and regulatory frameworks involved in the establishment of pharmaceutical pricing in Canada.The AHC is also calling for a re-evaluation of the prices that have been established for curative Hepatitis C (HCV) medicines that came to market beginning in 2014.Background The announcement of highly effective curative HCV treatments in 2014 – twenty-five years a...

Action Hepatitis Canada Age Cohort Testing Position Statement

Position StatementHepatitis C Age Cohort TestingAction Hepatitis Canada (AHC) calls for all adults born between 1945 and 1975 to be offered a one-time blood test for the hepatitis C virus (HCV).Canada’s current screening guidelines recommend HCV testing for people with known risk factors for the infection including: people who use drugs; prisoners; those who were born, traveled or lived in a region with a high prevalence of HCV; people who received healthc

World Health Organization VIRAL HEPATITIS Resolution passes

Read the unanimous UN/WHO resolution in full here: http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_R18-en.pdf From IP-Watch article: "The resolution asks states to consider using the flexibilities endorsed in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to promote access to specific pharmaceutical products. The director general is also asked to provide necessary technical support to countries, in